Jessica Rosario
General Practice · Santurce, PRNPI 1013035013
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,750 of the $40,830 with a category attached, or 72.9%. Viiv Healthcare Company accounts for 77.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $10,392 and has fallen 74.1% since, to $2,695 in 2025. Among general practice clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $167.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$31K
- Merck$4K
- Gilead$2K
- Theratechnologies Inc.$2K
- Johnson & Johnson$1K
- AbbVie$125
- plus $225 from 5 others
What the payments were for
- Consulting fees$29,75073%
- Speaking & faculty fees$1,1253%
- Travel & lodging$4881%
- Food & beverage$9,43723%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 65 | $31,474 |
| Merck | 33 | $3,635 |
| Gilead | 56 | $2,163 |
| Theratechnologies Inc. | 24 | $1,742 |
| Johnson & Johnson | 58 | $1,467 |
| AbbVie | 1 | $125 |
| Novartis | 3 | $72 |
| Hologic Sales And Service, LLC | 1 | $72 |
| Janssen Products, LP | 1 | $30 |
| Exact Sciences | 1 | $25 |
| GSK | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,830 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 209 | $907,789 |
| DovatoDolutegravir Sodium/Lamivudine | 116 | $352,183 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 76 | $334,202 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 65 | $323,341 |
| JulucaDolutegravir/Rilpivirine | 84 | $308,982 |
| TivicayDolutegravir Sodium | 103 | $248,821 |
| DescovyEmtricitabine/Tenofov Alafenam | 101 | $226,665 |
| PrezcobixDarunavir/Cobicistat | 70 | $181,703 |
| Isentress HdRaltegravir Potassium | 79 | $156,973 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 42 | $152,449 |
| PifeltroDoravirine | 49 | $89,391 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 18 | $71,891 |
| PrezistaDarunavir | 22 | $46,647 |
| IsentressRaltegravir Potassium | 11 | $21,792 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $13,325 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato, Triumeq, Juluca, Tivicay | $31,474 | $1,244,188379 claims |
| GileadBiktarvy, Descovy, Genvoya | $2,163 | $1,206,345328 claims |
| Janssen Products, LPSymtuza | $30 | $323,34165 claims |
| MerckIsentress Hd, Pifeltro, Isentress, Januvia | $3,635 | $274,509150 claims |
| Johnson & JohnsonPrezcobix | $1,467 | $181,70370 claims |
| GSKTrelegy Ellipta | $25 | $13,32520 claims |
| AbbVieSynthroid | $125 | $1,24723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Other general practice in Santurce
- Maria SotoSanturce$5K
- Wilfredo CuevasSan Lorenzo$530K
- Julio BacoMayaguez$268K
- Soria Diaz BaezPonce$192K
- Carlos RomanCanovanas$140K
- William E TorresSan Juan$86K
- Rafael Mendoza RodriguezPonce$77K
- Frank Perez NogueiraSan German$70K
- Vivian Tamayo AgraitSan Juan$64K
- William Soto AvilesToa Baja$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.